High BMI (n = 21) (%) | Normal BMI (n = 79) (%) | p value | |
---|---|---|---|
Age (years) | 67.5 ± 6.0 | 65.6 ± 10.6 | 0.4361 |
Gender | 0.1153 | ||
Male | 18 (85.7) | 54 (68.4) | |
Female | 3 (14.3) | 25 (31.6) | |
SFA (cm2) | 155.2 ± 35.8 | 105.3 ± 53.4 | 0.0001 |
VFA (cm2) | 155.0 ± 41.1 | 69.5 ± 41.7 | <0.0001 |
Tumor location | 0.5773 | ||
U | 2 (9.5) | 10 (12.7) | |
M | 12 (57.1) | 35 (44.3) | |
L | 7 (33.3) | 34 (43.0) | |
Macroscopic type | 0.6873 | ||
Superficial | 6 (28.6) | 25 (31.6) | |
Well-defined | 9 (42.9) | 26 (32.9) | |
Ill-defined | 6 (28.6) | 28 (35.4) | |
Tumor size (mm) | 50.1 ± 35.8 | 56.4 ± 27.9 | 0.3898 |
Histological type | 0.9490 | ||
Differentiated | 11 (52.4) | 42 (53.2) | |
Undifferentiated | 10 (47.6) | 37 (46.8) | |
Depth of invasion | 0.5844 | ||
T1 | 5 (23.8) | 28 (41.2) | |
T2 | 9 (42.9) | 16 (23.5) | |
T3 | 7 (33.3) | 24 (35.3) | |
Lymph-node metastasis | 0.4651 | ||
N0 | 7 (33.3) | 28 (40.0) | |
N1 | 9 (42.9) | 27 (38.6) | |
N2 | 5 (23.8) | 12 (17.1) | |
N3 | 0 (0) | 3 (4.3) | |
Stage | 0.5214 | ||
IA | 4 (19.0) | 18 (22.8) | |
IB | 4 (19.0) | 18 (22.8) | |
II | 3 (14.3) | 19 (24.1) | |
IIIA | 6 (28.6) | 11 (13.9) | |
IIIB | 3 (14.3) | 6 (7.6) | |
IV | 1 (4.8) | 7 (8.9) | |
Preoperative complications | 0.9055 | ||
Absence | 12 (57.1) | 44 (55.7) | |
Presence | 9 (42.8) | 35 (44.3) | |
LigaSure Atlas | 0.4614 | ||
Used | 12 (57.1) | 38 (48.1) | |
Not used | 9 (42.9) | 41 (51.9) | |
Operative procedure | 0.5091 | ||
Distal gastrectomy | 8 (53.3) | 53 (62.4) | |
Total gastrectomy | 7 (46.7) | 32 (37.6) | |
Splenectomy | 0.9817 | ||
Absence | 16 (76.2) | 60 (75.9) | |
Presence | 5 (23.8) | 19 (24.1) |